Formulation of Dosage Forms
FORMULATION AND EVALUATION OF GATIFLOXACIN TOPICAL SEMISOLID DOSAGE FORMS
... pharmaceutical dosage forms like semisolidsTopical preparations are used for the localized effects at the site of their application by virtue of drug penetration into the underlying layers of skin or mucous ...
20
FORMULATION AND EVALUATION OF ORODISPERSIBLE DOSAGE FORMS INCORPORATING DRUG NANOPARTICLES CONTAINING CLOPIDOGREL BISULPHATE
... liquid dosage forms of Clopidogrel ...optimized formulation of Clopidogrel bisulphate could improve the rate of absorption controlled by the rate of ...
18
Formulation of solid dosage forms using natural ingredients and novel method development for estimation of drug content
... the formulation of solid dosage forms, using natural ingredients and a novel method development for the estimation of individual ingredients in various combination ...novel formulation is ...
6
APPROACHES TO DEVELOPMENT OF SOLID – SELF MICRON EMULSIFYING DRUG DELIVERY SYSTEM: FORMULATION TECHNIQUES AND DOSAGE FORMS: A REVIEW
... solid dosage forms (SME tablets 2 and SME pellets 3 and so ...solid dosage forms, such as low production cost, convenience of process control, high stability and reproducibility, better ...
9
Anti microbial activity of different dosage forms of Bakuchi (Psoralea corylifolia Linn.) taila, An Ayurvedic formulation
... different dosage forms of Bakuchi ...the dosage forms of Bakuchi shows good inhibitory activity against both gram positive and gram negative ...all dosage forms, Bakuchi gel was ...
5
Formulation and evaluation of trimetazidine hydrochloride and clopidogrel bisulphate multi unit solid dosage forms
... release formulation of trimetazidine hydrochloride microspheres and immediate release formulation of clopidogrel bisulphate layer–tablet which were planned to be used for future preparation of bilayer ...
6
FORMULATION APPROACHES FOR SUSTAINED RELEASE DOSAGE FORMS: A REVIEW
... of dosage forms in the absorptive areas of GI tract is about 8-12 hrs, the maximum half-life for absorption should be approximately 3-4 ...the dosage form will pass out of absorptive regions before ...
8
FORMULATION AND DEVELOPMENT OF NOVEL AND STABLE DOSAGE FORMS OF LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS BY WET GRANULATION TECHNIQUE
... ABSTRACT: Antiretroviral drugs are medications used for treatment of infection caused by retroviruses, primarily HIV. Different classes of antiretroviral drugs act at different stages of the HIV life cycle. No individual ...
5
FORMULATION AND EVALUATION OF TINIDAZOLE MODIFIED RELEASE DOSAGE FORMS
... The aim of the present study was to design drug- cyclodextrin complex to improve dissolution for improvement in bioavailability, to reduce the dosing frequency and to improve patient compliance. The objectives of the ...
7
Formulation and evaluation of Lomefloxacin HCl as semisolid dosage forms
... The test was carried out as described in the literature [11,17]. Samples, each of 100 grams, of the tested formulation were packaged in tightly closed plastic-containers and kept at refrigerator (2 °C ) , ...
7
FORMULATION AND EVALUATION OF ALCOHOL RESISTANT DOSAGE FORMS OF GLIPIZIDE
... The reproducibility of the release characteristics from pellet formulations is also much better when compared to the single-unit dosage forms. They are suitable systems for film coating because of the low ...
5
Formulation and Evaluation of Cefixime Floating Matrix Tablets
... Bioadhesive drug delivery systems (BDDS) are used to localise a delivery device within the lumen to enhance the drug absorption in a site-specific manner. This approach involves the use of bioadhesive polymers, which can ...
117
FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms
... the dosage form adequately, it is recognized that a drug release profile should be generated, in which release (dissolution) values are determined as a function of ...oral dosage forms for some time ...
16
Formulation and In Vitro Evaluation of Lamivudine and Zidovudine Controlled Release Bilayer Matrix Tablets.
... of dosage forms (either solid or liquid) they must be developed within the intrinsic characteristics of GI ...and formulation design is essential to achieve a systematic approach to the successful ...
155
“Buccal Drug Delivery System: A Review” by Reena Sheoran, India.
... the dosage form in accordance with need, and comparatively less susceptibility to enzymatic ...mucosal dosage forms were prepared for oral delivery, in the form of adhesive tablets 5, 6 , adhesive ...
7
Title: ANTICONVULSANT SCREENING OF HYDRO-ALCOHOLIC ROOT EXTRACT OF BERBERIS ARISTATA IN MICE Author: Chauhan S. Suchita and Sharma K. Hemant Keyword: Anti-convulsant, Berberis aristata, MES, Pentylenetetrazole, Diazepam, Epilepsy.Page No: 01-06Abstract: Objective: To explore anti-convulsant potential of hydro-alcoholic extract of Berberis aristata (B. aristata) from pentylenetetrazole-induced and maximal electroshock (MES) seizure test. Material & Me thods: The test groups receive different doses (50, 100, 250 and 500 mg/kg) of the hydro-alcoholic extract; however positive control (standard) Phenobarbitone (20 mg/kg) using for Pentylenetetrazole-induced Seizure and Diazepam (1mg/kg) used as standard for maximal electroshock induced seizure. Swiss albino mice weigh about 20-25 g of either sex selected for the investigation. Results: Phytochemical investigation reveals that occurrence of alkaloids, flavonoids in the hydro-alcoholic root extract of Berberis aristata. Acute toxicity study shows no morality action up to 1000 mg/kg dose after 72 h observation. Hydro-alcoholic extract of B. aristata offered a concentration depending upon act of pentylenetetrazole-induced seizure (PTZ) and maximal electroshock induced seizure (MES). Conclusions: These finding suggest that hydro-alcoholic extract of B. aristata remarkable effect in the treatment in epilepsy. Key-words: Anti-convulsant, Berberis aristata, MES, Pentylenetetrazole, Diazepam, Epilepsy. Download PDF
... The calculation is based on allowing not more than a fraction of a therapeutic dose to be present in the subsequent product. The fraction in this case is called “Safety factor”. For example, the acceptance limit ...
9
ADDITIVES IN TOPICAL DOSAGE FORMS
... synthesis, excretion and absorption are main functions. Extent and the rate of drug absorption from the skin is affected by skin condition and formulation excipients. Topical dosages form like ointment, cream, ...
19
Formulation and Evaluation of Mouth Dissolving Films Containing Tizanidine Hydrochloride
... The formulation of a mouth dissolving film for Tizanidine, a muscle relaxant, BCS Class II drug has been an interesting topic of research compared to other oral dosage ...release, formulation F1 has ...
9
SOLID DISPERSION- STRATEGY TO ENHANCE SOLUBILITY AND DISSOLUTION OF POORLY WATER SOLUBLE DRUGS
... Improving oral bioavailability of drugs those given as solid dosage forms remains a challenge for the formulation scientists due to solubility problems. Over the years a variety of solubilization ...
6
REVIEW ON SURGE DRUG DELIVERY TECHNOLOGY
... release dosage forms with advantages and draw- backs on the basis of this it is concluded that Surge Delivery formulation offer advantages over the new, intensely advanced second generation fast ...
7